Innate Pharma to host conference call and webcast on september 17 for first half 2026 financial results and business update

Thu, 09/10/2026 - 07:00

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”), today announced that the Company will hold a conference call on Thursday, September 17, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT, to provide a business update for the first half of 2026.

Participants in the call will be:

Jonathan Dickinson, Chief Executive Officer

Markus Jensen, Vice President, Chief Medical Officer

Yannis Morel, Executive Vice President, Chief Operating Officer

Frédéric Lombard, Senior Vice President, Chief Financial Officer

Event Details

Date and time: September 17, 2026, at 2:00 p.m. CEST / 8:00 a.m. EDT

Webcast link: Click here

Conference call link: Click here

This information is also available on the Investors section of the Innate Pharma website, www.innate-pharma.com . A replay of the webcast will be available on the Company website for 90 days following the event.